This is an update on fourth quarter results of Max Healthcare Institute Limited.
Company reported consolidated revenues of INR 1214 crore in Q4, a y-o-y growth of 29.4% and q-o-q growth of 6.4%. EBITDA margin, during this financial year, has been much higher than that of last year and the trend continued in this quarter as it grew by 560 bps y-o-y. Sequentially, margins improved by 50 bps and were back to Q2 levels.
Company’s performance continues to be on an upward trajectory backed by addition of beds, consistently high utilization, lower public sector bed share, higher share of international patients and changes in specialty mix. And as per the management, they continue to exploit these levers to further improve both financial and operational metrics. Continue to watch the video for more details.
We invested in the stock at Rs 493.99. For all our current investments click here.
You may watch our note on Q3 results here: Max Healthcare Institute Ltd’s Q3FY23 Results
You may also like
Be First to Comment